Moderna is spending aggressively to broaden the uses of its mRNA technology. Investors are losing patience. Moderna is spending aggressively to broaden the uses of its mRNA technology. Investors are losing patience.

​WSJ.com: Markets

WE WANT YOU!

are you a developer?

  • Proven International Track Record
  • Vertically Integrated Federal Funds
  • Vertically Integrated Tax Credits
  • Vertically Integrated Investors
  • Vertically Integrated Lenders
  • Vertically Integrated Contractors